We detected the existence of CRP-SAA in the mixed serum sample from 10 lung cancer patients on which we previously performed the proteomics analysis (Fig. 2a) and some serum samples from individual lung cancer patients (Fig. 2b) by co-IP. This evidence concerns the gene SAA2 and lung carcinoma.